PRAME anticorps (N-Term)
-
- Antigène Voir toutes PRAME Anticorps
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PRAME est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- PRAME antibody was raised against the N terminal of PRAME
- Purification
- Affinity purified
- Immunogène
- PRAME antibody was raised using the N terminal of PRAME corresponding to a region with amino acids MERRRLWGSIQSRYISMSVWTSPRRLVELAGQSLLKDEALAIAALELLPR
- Top Product
- Discover our top product PRAME Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
PRAME Blocking Peptide, catalog no. 33R-5955, is also available for use as a blocking control in assays to test for specificity of this PRAME antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PRAME antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
- Autre désignation
- PRAME (PRAME Produits)
- Synonymes
- anticorps PRAME, anticorps CT130, anticorps MAPE, anticorps OIP-4, anticorps OIP4, anticorps 4930534P07Rik, anticorps preferentially expressed antigen in melanoma, anticorps PRAME, anticorps Prame
- Sujet
- PRAME functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. PRAME prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.
- Poids moléculaire
- 56 kDa (MW of target protein)
- Pathways
- Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding
-